Wave Life Sciences to discontinue development of suvodirsen for DMD

The results from the clinical study rendered no change from baseline in dystrophin expression Clinical stage genetic medicines company- Wave Life Sciences Ltd. has reportedly announced the halt of suvodirsen development for patients suffer....

Amazon receives final approval for development of HQ2 in Pentagon City

Amazon, the renowned American multinational technology giant, has reportedly received approval for the first phase of its HQ2 headquarters being built in Northern Virginia. Officials from the Arlington County Board collectively voted in fa....

Roche announces new data from Phase 3 FeDeriCa trial for breast cancer

Roche Holding, a renowned Swiss healthcare company working in pharmaceuticals and diagnostics, reportedly announced novel data from its Phase 3 FeDeriCa trial. The trial showed the investigational FDC (fixed-dose combination) of pertuzumab ....

Biothera unveils updated data from Phase 2 mTNBC trial at SABCS

Biothera Pharmaceuticals, Inc., a renowned Minnesota based biotechnology company, reportedly announced that clinical benefit data and updated response from its Phase 2 study in chemo-refractory mTNBC (metastatic triple negative breast cance....

argenx publishes positive results from efgartigimod Phase 2 ITP trial

argenx, a renowned Netherlands based biotechnology firm, reportedly announced the publication of outcomes from the assessment of its FcRn antagonist, efgartigimod, in a Phase 2 ITP clinical trial, in the American Journal of Hematology. Wim....

KCV inks composite assembly manufacturing deal with Carestream Health

Kaman Composites Vermont, also known as KCV and a subsidiary of Kaman Corporation, a renowned aerospace company, reportedly announced a manufacturing contract with Carestream Health, an independent subsidiary of Onex Corporation. Under thi....

Genentech announces updated data from Venclexta® clinical trials

Chronic lymphocytic leukemia (CLL) is a common type of adult leukemia. In the United States, it is estimated that more than 20,000 new cases of CLL will be diagnosed in 2019. With an eye to cure CLL, biotechnology company Genentech, Inc. ha....

AgraFlora announces acquisition of outstanding shares of Sanna

  Under the agreement terms, the company is required to pursue the acquisition of 100% of Sanna’s outstanding shares. The acquisition is anticipated to amplify the production capacity of AgraFlora to two times the current pro....

CoSara receives Indian regulatory authorization for its five IVDs

Co-Diagnostics, a renowned US-based molecular diagnostics company, having a patented, unique platform to develop diagnostics tests reportedly announced that CoSara Diagnostics, the company’s JV for production, has received regulatory ....

NantKwest announces Phase 1 results of PD-L1.t-haNK cell therapy

NantKwest Inc., a U.S.-based clinical-stage immunotherapy company, has reportedly announced encouraging safety data generated from the first six patients in its QUILT-3.064 clinical trial. The study is conducted to access the prelimina....